Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice

Vaccine

Volumn 15, Issue 11, 1997, Pages 1244-1251

  Hordnes, Knut ^a   Tynning, Turid ^a   Brown, Thomas A ^b   Haneberg, Bjørn ^c   Jonsson, Roland ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF FLORIDA   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Female genital tract; Group B streptococci; Immunoglobulin A

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; STREPTOCOCCUS ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL TRACT INFECTION; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; VAGINA SECRETION;

EID: 0030870842     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00021-2     Document Type: Article

References (50)

1. Noya, F.J. and Baker, C.J. Prevention of group B streptococcal infection. Infect. Dis. Clin. North Am. 1992, 6, 41-55.
2. Baker, C.J. and Edwards, M.S. Group B streptococcal infections. In: Infectious Diseases of the Fetus and the Newborn Infant (Eds Remington, U.S. and Klein, J.O.). W.B. Saunders, Philadelphia, 1990, pp. 742-811.
3. Michel, J.L., Madoff, L.C., Kling, D.E., Kasper, D.L. and Ausubel, F.M. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect. Immun. 1991, 59, 2023-2028.
4. Paoletti, L.C., Wessels, M.R., Michon, F., DiFabio, J., Jennings, H.J. and Kasper, D.L. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 1992, 60, 4009-4014.
5. Martin, T.R., Ruzinski, J.T., Rubens, C.E., Chi, E.Y. and Wilson, C.B. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J. Infect. Dis. 1992, 165, 306-314.
6. Madoff, L.C., Michel, J.L., Gong, E.W., Rodewald, A.K. and Kasper, D.L. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect. Immun. 1992, 60, 4989-4994.
7. Madoff, L.C., Paoletti, L.C., Tai, J.Y. and Kasper, D.L. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. 1994, 94, 286-292.
8. Rodewald, A.K., Onderdonk, A.B., Warren, H.B. and Kasper, D.L. Neonatal mouse model of group B streptococcal infection. J. Infect. Dis. 1992, 166, 635-639.
9. Stålhammar Carlemalm, M., Stenberg, L. and Lindahl, G. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 1993, 177, 1593-1603.
10. Wessels, M.R., Paoletti, L.C. and Rodewald, A.K. et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 1993, 61, 4760-4766.
11. Paoletti, L.C., Kennedy, R.C., Chanh, T.C. and Kasper, D.L. Immunogenicity of group B streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infect. Immun. 1996, 64, 677-679.
12. Flores, A.E., Nelson, J.A., Wu, X.Y. and Ferrieri, P. Antibody profiles to the group B streptococcal beta antigen in maternal and infant paired sera. APMIS 1993, 101, 41-49.
13. Boyer, K.M., Papierniak, C.K., Gadzala, C.A., Parvin, J.D. and Gotoff, S.P. Transplacental passage of IgG antibody to group B streptococcus serotype Ia. J. Pediatr. 1984, 104, 618-620.
14. Hordnes, K., Digranes, A. and Haugen, I.L. et al. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa. J. Reprod. Immunol. 1995, 28, 247-262.
15. Hordnes, K., Tynning, T., Kvam, A.I., Jonsson, R. and Haneberg, B. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Infect. Immun. 1996, 64, 1643-1652.
16. Shroff, K.E., Meslin, K. and Cebra, J.J. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 1995, 63, 3904-3913.
17. Neutra, M.R. and Kraehenbuhl, J.P. Transepithelial transport and mucosal defence I: the role of M cells. Trends. Cell. Biol. 1992, 2, 134-138.
18. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C.K. and Koenig, S. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 1994, 372, 552-555.
19. Hopkins, S., Kraehenbuhl, J.P. and Schodel, F. et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 1995, 63, 3279-3286.
20. Gallichan, W.S. and Rosenthal, K.L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995, 13, 1589-1595.
21. Gallichan, W.S., Johnson, D.C., Graham, F.L. and Rosenthal, K.L. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 1993, 168, 622-629.
22. de Haan, A., Renegar, K.B., Small, P.A. < jrJr and Wilschut, J. Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. Vaccine 1995, 13, 613-616.
23. Yetter, R.A., Lehrer, S., Ramphal, R. and Small, P.A.J. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 1980, 29, 654-662.
24. Haneberg, B., Kendall, D., Amerongen, H.M., Apter, F.M., Kraehenbuhl, J.P. and Neutra, M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62, 15-23.
25. Kagnoff, M.F. Humoral antibody responses to the bacterial polysaccharide dextran B1355. Ann. N.Y. Acad. Sci. 1983, 409, 114-128.
26. Wu, H.Y. and Russell, M.W. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity. Vaccine 1994, 12, 215-222.
27. Wu, H.Y. and Russell, M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 1993, 61, 314-322.
28. Di Tommaso, A., Saletti, G. and Pizza, M. et al. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 1996, 64, 974-979.
29. Russell, M.W., Moldoveanu, Z., White, P.L., Sibert, G.J., Mestecky, J. and Michalek, S. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 1996, 64, 1272-1283.
30. Kraehenbuhl, J.P. and Neutra, M.R. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 1992, 72, 853-879.
31. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88.
32. Elson, C.O. Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and Ips genes. Infect. Immun. 1992, 60, 2874-2879.
33. Holmgren, J., Czerkinsky, C., Lycke, N. and Svennerholm, A.M. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 1994, 50, 42-54.
34. Elson, C.O., Holland, S.P., Dertzbaugh, M.T., Cuff, C.F. and Anderson, A.O. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 1995, 154, 1032-1040.
35. Bromander, A.K., Kjerrulf, M., Holmgren, J. and Lycke, N. Cholera toxin enhances antigen presentation. Adv. Exp. Med. Biol. 1995, 371B, 1501-1506.
36. Vancott, J.L., Kobayashi, T., Yamamoto, M., Pillai, S., McGhee, J.R. and Kiyono, H. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization. Vaccine 1996, 14, 392-398.
37. Vadolas, J., Davies, J.K., Wright, P.J. and Strugnell, R.A. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 1995, 25, 969-975.
38. Quiding, M., Lakew, M., Granstrom, G., Nordstrom, I., Holmgren, J. and Czerkinsky, C. Induction of specific antibody responses in the human nasopharyngeal mucosa. Adv. Exp. Med. Biol. 1995, 371B, 1445-1450.
39. Sun, J.B., Holmgren, J. and Czerkinsky, C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance [see comments]. Proc. Natl Acad. Sci. USA 1994, 91, 10795-10799.
40. Berstad, A.K.H., Holst, J., Møgster, B., Haugen, I.L. and Haneberg, B. Cholera toxin can inhibit IgA antibody responses to intranasally delivered Bordetella pertussis IgA. Abstract P02. IABS Task Force on Vaccines. Modulation of the Immune Response to Vaccine Antigens. Bergen, 18-21 June 1996.
41. Bergquist, C., Lagergard, T., Lindblad, M. and Holmgren, J. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 1995, 63, 2021-2025.
42. Bessen, D. and Fischetti, V.A. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J. Exp. Med. 1988, 167, 1945-1950.
43. Cantey, J.R. Prevention of bacterial infections of mucosal surfaces by immune secretory IgA. Adv. Exp. Med. Biol. 1978, 107, 461-470.
44. Fubara, E.S. and Freter, R. Protection against enteric bacterial infection by secretory IgA antibodies. J. Immunol. 1973, 111, 395-403.
45. Katz, J., Harmon, C.C., Buckner, G.P., Richardson, G.J., Russell, M.W. and Michalek, S.M. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect. Immun. 1993, 61, 1964-1971.
46. Orr, N., Robin, G., Cohen, D., Arnon, R. and Lowell, G.H. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect. Immun. 1993, 61, 2390-2395.
47. Bout, D., Buzoni Gatel, D., Chardes, T., Debard, N. and Mevelec, M.N. Mucosal vaccination against toxoplasmosis. Vet. Res. 1995, 26, 214-215.
48. Nedrud, J.G., Liang, X.P., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 1987, 139, 3484-3492.
49. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 1993, 90, 11478-11482.
50. Marx, P.A., Compans, R.W. and Gettie, A. et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993, 260, 1323-1327.